Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGA| |CTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACC
End
32768495/32277589 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/11878235; hsa-let-7e/Downstream/2845111;
Upstream sequence
agataacaaggcaagattatgaacaacttaattctcgtatatttgacagtgtatatgaaatgaacagatttattgaggattttgattcatcaaaagggat
Downstream sequence
attagaagaaatagaaaatctgtaaaagtcttaattccattaaagaagttgaatttgtaatcaaaagcaaacttgaggactaatggtttcactggtgaat
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.